Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,699.50
Bid: 1,699.00
Ask: 1,700.00
Change: 26.50 (1.58%)
Spread: 1.00 (0.059%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stock markets flat ahead of quiet day

Fri, 13th Mar 2015 09:06

UK stocks were more or less flat in early deals on Friday ahead of a quiet day for the markets in terms of economic data and corporate news.London's FTSE 100 was trading up just 0.01% at 6,761.79 early on.As it stands, the Footsie is still nearly 3% lower than where it stood last Friday as a strengthening pound and weak Chinese data weighed on commodity prices, while ongoing concerns about Greek continued to hit sentiment.Friday is set to be a quiet day in terms of economic data, with UK construction output, the US producer price index (PPI) and University of Michigan (UoM) consumer confidence survey the only major indicators being released."The PPI reading can be a good indicator of future inflation so is worth tracking, while the UoM reading could give some insight into consumer spending expectations ahead of the summer," said analyst Craig Erlam from Oanda.Afren plunges on recapitalisation planShares in Afren tumbled after the struggling oil and gas group proposed a debt-for-equity swap with creditors to address its funding needs and recapitalise its capital structure. The company said it "will result in substantial dilution for existing shareholders", and if shareholders don't approve the plan, the company will have no choice but to initiate a sale.Glasxosmithkline edged lower after selling half its stake in former South African associate Aspen Pharmacare for £0.57bn. Having sold 28.2m shares, at a price of 372 rand per share, GSK now holds a 6.2% stake in Aspen, South Africa's largest drug company.JD Wetherspoon served up a slightly short measure of first-half profits as the pubs group saw cost pressures outweigh a rise in revenues. Profits declined 0.9% in the first half while the interim dividend was maintained, causing shares to fall in London.Costa and Premier Inn owner Whitbread was racking up gains after UBS upgraded the stock to 'neutral' and Deustche Bank raised it to 'buy', while spirits group Diageo was lower after a downgrade by Credit Suisse to 'underperform'.Market MoverstechMARK 3,177.56 +0.33%FTSE 100 6,761.79 +0.01%FTSE 250 17,109.41 +0.28%FTSE 100 - RisersWhitbread (WTB) 5,400.00p +2.66%ARM Holdings (ARM) 1,180.00p +1.55%Meggitt (MGGT) 568.00p +1.52%Wolseley (WOS) 4,110.00p +1.46%British Land Co (BLND) 816.00p +1.37%Antofagasta (ANTO) 709.00p +1.21%GKN (GKN) 366.30p +1.19%Carnival (CCL) 3,132.00p +1.13%Fresnillo (FRES) 660.50p +1.07%Land Securities Group (LAND) 1,210.00p +1.00%FTSE 100 - FallersDiageo (DGE) 1,850.00p -1.70%SSE (SSE) 1,471.00p -1.34%Travis Perkins (TPK) 1,942.00p -1.27%Centrica (CNA) 238.60p -1.16%BG Group (BG.) 829.20p -1.12%Smiths Group (SMIN) 1,153.00p -1.11%BP (BP.) 421.95p -0.92%Sage Group (SGE) 472.40p -0.92%BHP Billiton (BLT) 1,424.00p -0.80%Ashtead Group (AHT) 1,107.00p -0.54%FTSE 250 - RisersThomas Cook Group (TCG) 155.10p +4.37%St. Modwen Properties (SMP) 454.50p +2.83%Bwin.party Digital Entertainment (BPTY) 81.75p +2.64%Allied Minds (ALM) 635.00p +2.50%Ladbrokes (LAD) 114.10p +2.33%Just Eat (JE.) 340.00p +2.22%Just Retirement Group (JRG) 155.20p +2.11%Workspace Group (WKP) 829.50p +2.09%Intermediate Capital Group (ICP) 483.80p +2.07%Grafton Group Units (GFTU) 780.00p +2.03%FTSE 250 - FallersAfren (AFR) 5.50p -15.38%Cairn Energy (CNE) 155.70p -3.41%Soco International (SIA) 153.40p -3.28%Wetherspoon (J.D.) (JDW) 785.00p -3.27%Hikma Pharmaceuticals (HIK) 2,288.00p -2.84%Lonmin (LMI) 107.90p -2.53%Vedanta Resources (VED) 514.50p -2.46%Cranswick (CWK) 1,378.00p -2.20%Premier Oil (PMO) 134.60p -1.97%Spire Healthcare Group (SPI) 323.70p -1.91%
More News
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.